We're working with TechCrunch on a more in-depth series of posts, including one that will cover the classification and regulation around the three broad classes of compounds: 'supplements', 'prescription', and 'unregulated' research chemicals. We'll get into the world of noopept, piracetam, and DARPA-funded peptides etc. for you guys.